10/26/2011 - 1:03pm

Despite concerns about the economy and rising household expenses, nearly 3-out-of-5 consumers (59%) will put aside economic worries and spend the same or more this holiday season, according to Deloitte’s 26th annual survey of holiday spending intentions and trends.

10/26/2011 - 10:34am

Twenty-four percent of patients given a new medication by their doctor did not fill the prescription, according to a new study by researchers at Harvard University, Brigham and Women's Hospital and CVS Caremark.

10/24/2011 - 10:17am

More than three-quarters of patients with multiple sclerosis using a drug made by Sanofi subsidiary Genzyme did not experience disease relapse for two years, according to results of a late-stage clinical trial revealed over the weekend.

10/21/2011 - 4:16pm

Sanofi Pasteur, the vaccines division of Sanofi, released data from a new study examining the ability of its Fluzone High-Dose vaccine to provoke an immune response in elderly and younger adults, compared with a standard dose of Fluzone vaccine.

10/21/2011 - 1:35pm

A study conducted by the University of Alberta found that women with Type 2 diabetes have an increased risk of developing breast cancer.

10/21/2011 - 1:05pm

A new study conducted by the Joslin Diabetes Center suggested that a certain enzyme could cause birth defects among babies born to women with diabetes.

10/21/2011 - 11:22am

More than 1-in-10 Americans ages 12 years and older take antidepressants, and the rate of antidepressant use in the United States among all ages increased 400% between 1988 and 2008, according to a new report by the Centers for Disease Control and Prevention's National Center for Health Statistics.

10/20/2011 - 3:12pm

Economic anxiety continues to plague U.S. consumers, with 84% planning to spend the same or less this holiday season, according to a new report released by GfK Custom Research North America on Thursday.

10/20/2011 - 10:41am

Mobile retail websites have emerged as an indispensible in-store tool for consumers as they shop, according to a new survey conducted by Hipcricket, an Augme Technologies company, that was released Thursday.